KRM Ayurveda Limited
Promoters Puneet Dhawan · Tanya Dhawan
Against an issue price of ₹135. Split- and bonus-adjusted official closes — a past move, never a forecast.
KRM Ayurveda Limited raised ₹71 crore through a SME-platform initial public offer.
The filing places it in Pharmaceuticals & Biotechnology and names two promoters: Puneet Dhawan and Tanya Dhawan.
The book was open from 21 January 2026 to 23 January 2026.
The issue was priced at ₹135 a share, from a band of ₹128 to ₹135.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
The shares listed on 29 January 2026.
The last official close on file is ₹235 (5 November 2026), which is 74.3% above the issue price.
It now trades as KRMAYURVED, and its filed financials are on its company page.
Shares sold in the issue at ₹135 last closed at ₹235.35.
See KRMAYURVED’s filed financials and price history →Official exchange closes, restated for splits, bonuses and rights issues since listing. A record of past price movement, not a forecast.
- How it was priced
- Book-built — the price was discovered inside a band from the bids received
- Listing sought at
- NSE
- Registered office
- Northern India
- Company website
- www.krmayurvedaindia.com
- Registrar
- Skyline Financial Services Private Limited
- Lead manager
- Other LM / BRLM
- Bidding opens21 Jan 2026
- Bidding closes23 Jan 2026
- Basis of allotmentnot published
Not published in the exchange feeds we ingest — we do not estimate it.
- Listing29 Jan 2026
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We have not extracted an anchor allotment list for this issue.
- All other pre-issue capitalSEBI ICDR 2018 Reg. 17 — all other pre-issue capital, 6 months from allotment29 Jul 2026already free
- Promoters' minimum contributionSEBI ICDR 2018 Reg. 16(1)(a) — promoters' minimum contribution, 18 months from allotment29 Jul 2027whole tranche releases on this date
Computed from the SEBI ICDR 2018 lock-in rules, not disclosed by the issuer or the exchange. The regulation counts from the date of allotment, which no feed we ingest publishes, so these are counted from the listing date and fall at most two to three business days later than the true expiry.
The "Basis for Offer Price" chapter states the earnings the price was set against and the multiples it implies. We have not extracted it for this issue — several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
The offer document must name the listed companies the issuer considers comparable, and print their valuation figures beside its own. This is that list — the issuer’s choice of comparison, not ours.
| Company | P/E | P/B | RoNW | EPS | Income |
|---|---|---|---|---|---|
| Jeena Sikho Lifecare Limited | 77.2 | — | 31.3% | — | — |
| Vaidya Sane Ayurved Laboratories Limited | 76.2 | — | 5.1% | — | — |
The issuer's own figures as printed at the head of the same table — its claim about itself, on the same basis as its claims about the companies below.
Figures as PRINTED by the issuer in its own offer document. The comparison set is the issuer's choice, not ours.
| Firm | Issues | Typical listing move | Below issue @30d | @90d | @180d |
|---|---|---|---|---|---|
Skyline financial services private limited 2021 – 2026 | 79 2 measurable | +12.3% | 1 of 3 | 1 of 3 | 1 of 4 |
A count of what happened to the other issues each firm was named on, computed from exchange closes. Not a rating, not a ranking, and not a view on the firm.
- Prospectus· PDF · exchange archive27 Jan 2026
- Red herring prospectus (RHP)· ZIP · exchange archive15 Jan 2025
- Draft red herring prospectus (DRHP)· ZIP · exchange archive22 Sept 2025
- Financial ratios advertisement· ZIP · exchange archive
- In-principle approval (XBRL)· XML · exchange archive
Filed with SEBI and the exchanges by the issuer. These are the source for every figure on this page.
Compiled from NSE and SEBI offer documents and exchange feeds. A description of the issue and of the bids received — not investment advice, and not a view on whether to apply. No grey-market premium, no allotment lookup and no listing-gain estimate is published here.